During surgery for aortic arch aneurysm under deep hypothermic circulatory arrest which of the following anaesthetic agent administered prior to circulatory arrest that also provides cerebral protection?
**Core Concept**
Thiopental Sodium is a barbiturate that provides cerebral protection by reducing metabolic rate and suppressing electrical activity in the brain, making it an ideal agent for use during deep hypothermic circulatory arrest (DHCA) in aortic arch aneurysm surgery.
**Why the Correct Answer is Right**
Thiopental Sodium works by inhibiting the activity of the enzyme adenylyl cyclase, which is involved in the production of cyclic AMP (cAMP), a key second messenger in the brain. This inhibition leads to a decrease in the activity of protein kinase A (PKA), resulting in reduced phosphorylation of key enzymes involved in glycolysis. As a result, glucose utilization is decreased, and the brain's metabolic rate is reduced. Additionally, thiopental sodium can induce a state of burst suppression on the electroencephalogram (EEG), which is characterized by periods of low voltage activity interspersed with brief periods of high voltage activity. This state provides additional protection against cerebral ischemia during DHCA.
**Why Each Wrong Option is Incorrect**
**Option A:** Etomidate is a carboxylated imidazole that provides sedation and hypnosis, but it does not provide the same level of cerebral protection as thiopental sodium. Etomidate can actually increase intracranial pressure and is not ideal for use in patients with head trauma or intracranial hypertension.
**Option C:** Propofal is a short-acting sedative-hypnotic agent that is commonly used for induction and maintenance of anesthesia. However, it does not have the same cerebral protective effects as thiopental sodium and can actually increase the risk of seizures in certain patients.
**Option D:** Ketamine is a dissociative anesthetic agent that provides analgesia and sedation, but it can increase cerebral blood flow and metabolism, which may not be desirable during DHCA.
**Clinical Pearl / High-Yield Fact**
When using thiopental sodium for cerebral protection during DHCA, it is essential to ensure that the patient is adequately hypothermic (typically between 18-20°C) to maximize the protective effects of the agent.
**✓ Correct Answer: B. Thiopental Sodium**